{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:45:07Z","timestamp":1789677907651,"version":"4.0.1"},"reference-count":107,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:00:00Z","timestamp":1648684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Hemostasis, thrombosis, and inflammation are tightly interconnected processes which may give rise to thrombo-inflammation, involved in infectious and non-infectious acute and chronic diseases, including cardiovascular diseases (CVD). Traditionally, due to its hemostatic role, blood coagulation is isolated from the inflammation, and its critical contribution in the progressing CVD is underrated, until the full occlusion of a critical vessel occurs. Underlying vascular injury exposes extracellular matrix to deposit platelets and inflammatory cells. Platelets being key effector cells, bridge all the three key processes (hemostasis, thrombosis, and inflammation) associated with thrombo-inflammation. Under physiological conditions, platelets remain in an inert state despite the proximity to the endothelium and other cells which are decorated with glycosaminoglycan (GAG)-rich glycocalyx (GAGs). A pathological insult to the endothelium results in an imbalanced blood coagulation system hallmarked by increased thrombin generation due to losses of anticoagulant and cytoprotective mechanisms, i.e., the endothelial GAGs enhancing antithrombin, tissue factor pathway-inhibitor (TFPI) and thrombomodulin-protein C system. Moreover, the loss of GAGs promotes the release of mediators, such as von Willebrand factor (VWF), platelet factor 4 (PF4), and P-selectin, both locally on vascular surfaces and to circulation, further enhancing the adhesion of platelets to the affected sites. Platelet-neutrophil interaction and formation of neutrophil extracellular traps foster thrombo-inflammatory mechanisms exacerbating the cardiovascular disease course. Therefore, therapies which not only target the clotting mechanisms but simultaneously or independently convey potent cytoprotective effects hemming the inflammatory mechanisms are expected to provide clinical benefits. In this regard, we review the cytoprotective protease activated protein C (aPC) and its strong anti-inflammatory effects thereby preventing the ensuing thrombotic complications in CVD. Furthermore, restoring GAG-like vasculo-protection, such as providing heparin-proteoglycan mimetics to improve regulation of platelet and coagulation activity and to suppress of endothelial perturbance and leukocyte-derived pro-inflammatory cytokines, may provide a path to alleviate thrombo-inflammatory disorders in the future. The vascular tissue-modeled heparin proteoglycan mimic, antiplatelet and anticoagulant compound (APAC), dual antiplatelet and anticoagulant, is an injury-targeting and locally acting arterial antithrombotic which downplays collagen- and thrombin-induced and complement-induced activation and protects from organ injury.<\/jats:p>","DOI":"10.3389\/fcvm.2022.866751","type":"journal-article","created":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T07:56:46Z","timestamp":1648713406000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":49,"title":["Thrombosis and Inflammation\u2014A Dynamic Interplay and the Role of Glycosaminoglycans and Activated Protein C"],"prefix":"10.3389","volume":"9","author":[{"given":"Shrey","family":"Kohli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khurrum","family":"Shahzad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annukka","family":"Jouppila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Holth\u00f6fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berend","family":"Isermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riitta","family":"Lassila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart disease and stroke statistics-2021 update: a report from the American heart association.","volume":"143","author":"Virani","year":"2021","journal-title":"Circulation."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/j.cell.2021.01.049","article-title":"Increased stem cell proliferation in atherosclerosis accelerates clonal hematopoiesis.","volume":"184","author":"Heyde","year":"2021","journal-title":"Cell."},{"key":"B3","first-page":"2","article-title":"Atherogenesis and inflammation.","author":"Jang","year":"1993","journal-title":"Eur Heart J."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e176","DOI":"10.1161\/ATVBAHA.119.312578","article-title":"Myocardial infarction-from atherosclerosis to thrombosis.","volume":"39","author":"Palasubramaniam","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1055\/s-0040-1708035","article-title":"Thrombo-inflammation in cardiovascular disease: an expert consensus document from the third maastricht consensus conference on thrombosis.","volume":"120","author":"d\u2019Alessandro","year":"2020","journal-title":"Thrombosis Haemostasis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1055\/s-0034-1395157","article-title":"Mast cell-derived heparin proteoglycans as a model for a local antithrombotic.","volume":"40","author":"Lassila","year":"2014","journal-title":"Semin Thrombosis Hemostasis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"100733","DOI":"10.1016\/j.blre.2020.100733","article-title":"Interplay between platelets and coagulation.","volume":"46","author":"Sang","year":"2021","journal-title":"Blood Rev."},{"key":"B8","doi-asserted-by":"publisher","first-page":"711003","DOI":"10.3389\/fcell.2021.711003","article-title":"The endothelial glycocalyx as a double-edged sword in microvascular homeostasis and pathogenesis.","volume":"9","author":"Villalba","year":"2021","journal-title":"Front Cell Dev Biol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"739699","DOI":"10.3389\/fncel.2021.739699","article-title":"The structure and function of the glycocalyx and its connection with blood-brain barrier.","volume":"15","author":"Jin","year":"2021","journal-title":"Front Cell Neurosci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00281-011-0285-5","article-title":"Endothelium\u2013role in regulation of coagulation and inflammation.","volume":"34","author":"van Hinsbergh","year":"2012","journal-title":"Semin Immunopathol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1161\/01.atv.21.2.178","article-title":"Thromboregulation by endothelial cells: significance for occlusive vascular diseases.","volume":"21","author":"Marcus","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B12","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/HS9.0000000000000238","article-title":"Management of coagulation disorders in severe inflammation.","volume":"3","author":"Lassila","year":"2019","journal-title":"HemaSphere."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.3389\/fimmu.2019.02204","article-title":"The era of thromboinflammation: platelets are dynamic sensors and effector cells during infectious diseases.","volume":"10","author":"Guo","year":"2019","journal-title":"Front Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1515\/BC.2008.005","article-title":"Heparinase selectively sheds heparan sulphate from the endothelial glycocalyx.","volume":"389","author":"Chappell","year":"2008","journal-title":"Biol Chem."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1093\/cvr\/cvy167","article-title":"A disintegrin and metalloproteinase 15-mediated glycocalyx shedding contributes to vascular leakage during inflammation.","volume":"114","author":"Yang","year":"2018","journal-title":"Cardiovasc Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1093\/cvr\/cvy199","article-title":"ADAM-15 and glycocalyx shedding: a new perspective on sepsis-related vasomotor dysfunction.","volume":"114","author":"Horowitz","year":"2018","journal-title":"Cardiovasc Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"7734","DOI":"10.1073\/pnas.85.20.7734","article-title":"Complement receptor type three (CD11b\/CD18) of human polymorphonuclear leukocytes recognizes fibrinogen.","volume":"85","author":"Wright","year":"1988","journal-title":"Proc Natl Acad Sci USA."},{"key":"B18","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41569-018-0110-0","article-title":"Platelet biology and functions: new concepts and clinical perspectives.","volume":"16","author":"van der Meijden","year":"2019","journal-title":"Nat Rev Cardiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1172\/JCI111591","article-title":"Platelet interaction with rabbit subendothelium in von Willebrand\u2019s disease: altered thrombus formation distinct from defective platelet adhesion.","volume":"74","author":"Turitto","year":"1984","journal-title":"J Clin Invest."},{"key":"B20","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/192531a0","article-title":"Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets.","volume":"192","author":"Gaarder","year":"1961","journal-title":"Nature."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1161\/atvbaha.110.207522","article-title":"Signaling during platelet adhesion and activation.","volume":"30","author":"Li","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/194927b0","article-title":"Aggregation of blood platelets by adenosine diphosphate and its reversal.","volume":"194","author":"Born","year":"1962","journal-title":"Nature."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1073\/pnas.72.8.2994","article-title":"Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.","volume":"72","author":"Hamberg","year":"1975","journal-title":"Proc Natl Acad Sci USA."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/s0022-2275(20)38588-6","article-title":"Quantitative loss of individual eicosapentaenoyl-relative to arachidonoyl-containing phospholipids in thrombin-stimulated human platelets.","volume":"28","author":"Mahadevappa","year":"1987","journal-title":"J Lipid Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1182\/blood-2016-03-705434","article-title":"Maternal extracellular vesicles and platelets promote preeclampsia through inflammasome activation in embryonic trophoblast.","volume":"128","author":"Kohli","year":"2016","journal-title":"Blood."},{"key":"B26","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.tmrv.2020.09.005","article-title":"The immune nature of platelets revisited.","volume":"34","author":"Maouia","year":"2020","journal-title":"Transfusion Med Rev."},{"key":"B27","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1182\/blood-2012-01-405134","article-title":"Sequence and structure relationships within von Willebrand factor.","volume":"120","author":"Zhou","year":"2012","journal-title":"Blood."},{"key":"B28","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/s41569-021-00552-1","article-title":"Interplay between inflammation and thrombosis in cardiovascular pathology.","volume":"18","author":"Stark","year":"2021","journal-title":"Nat Rev Cardiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.3389\/fimmu.2019.02884","article-title":"von willebrand factor and platelet glycoprotein Ib: a thromboinflammatory axis in stroke.","volume":"10","author":"Denorme","year":"2019","journal-title":"Front Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.3390\/cells10092351","article-title":"The manifold cellular functions of von willebrand factor.","volume":"10","author":"Mojzisch","year":"2021","journal-title":"Cells."},{"key":"B31","doi-asserted-by":"publisher","first-page":"3212","DOI":"10.1182\/blood-2011-02-306597","article-title":"Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor.","volume":"118","author":"Crawley","year":"2011","journal-title":"Blood."},{"key":"B32","first-page":"55","article-title":"Von willebrand factor and adamts13 in covid-19 and beyond: a question of balance.","volume":"9","author":"Emmanuel","year":"2021","journal-title":"EMJ Hematol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"4712","DOI":"10.1182\/blood-2010-03-276311","article-title":"von Willebrand factor promotes leukocyte extravasation.","volume":"116","author":"Petri","year":"2010","journal-title":"Blood."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1182\/blood-2006-06-032524","article-title":"Adenovirus-induced thrombocytopenia: the role of von Willebrand factor and P-selectin in mediating accelerated platelet clearance.","volume":"109","author":"Othman","year":"2007","journal-title":"Blood."},{"key":"B35","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.thromres.2009.11.023","article-title":"Role of the platelet chemokine platelet factor 4 (PF4) in hemostasis and thrombosis.","volume":"125","author":"Kowalska","year":"2010","journal-title":"Thrombosis Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e99445","DOI":"10.1172\/jci.insight.99445","article-title":"Neutrophil accumulation and NET release contribute to thrombosis in HIT.","volume":"3","author":"Gollomp","year":"2018","journal-title":"JCI Insight."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S0140-6736(21)01608-1","article-title":"Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study.","volume":"398","author":"Perry","year":"2021","journal-title":"Lancet."},{"key":"B38","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/00000542-199501000-00023","article-title":"Platelet factor 4 injection produces acute pulmonary hypertension in the awake lamb.","volume":"82","author":"Kurrek","year":"1995","journal-title":"Anesthesiology."},{"key":"B39","doi-asserted-by":"publisher","first-page":"3352","DOI":"10.1073\/pnas.061615598","article-title":"Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis.","volume":"98","author":"Borsig","year":"2001","journal-title":"Proc Natl Acad Sci USA."},{"key":"B40","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.thromres.2011.04.018","article-title":"P-selectin ligation induces platelet activation and enhances microaggregate and thrombus formation.","volume":"128","author":"Theoret","year":"2011","journal-title":"Thrombosis Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1084\/jem.20021868","article-title":"Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin.","volume":"197","author":"Falati","year":"2003","journal-title":"J Exp Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1172\/JCI1509","article-title":"Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents.","volume":"101","author":"Koenig","year":"1998","journal-title":"J Clin Invest."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.4049\/jimmunol.1900899","article-title":"Platelets in inflammation and resolution.","volume":"203","author":"Margraf","year":"2019","journal-title":"J Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"13464","DOI":"10.1038\/ncomms13464","article-title":"Directed transport of neutrophil-derived extracellular vesicles enables platelet-mediated innate immune response.","volume":"7","author":"Rossaint","year":"2016","journal-title":"Nat Commun."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1096\/fj.01-0199com","article-title":"Platelet, but not endothelial, P-selectin is critical for neutrophil-mediated acute postischemic renal failure.","volume":"15","author":"Singbartl","year":"2001","journal-title":"FASEB J."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1016\/j.cell.2017.11.001","article-title":"Migrating platelets are mechano-scavengers that collect and bundle bacteria.","volume":"171","author":"Gaertner","year":"2017","journal-title":"Cell."},{"key":"B47","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nm.4294","article-title":"An emerging role for neutrophil extracellular traps in noninfectious disease.","volume":"23","author":"Jorch","year":"2017","journal-title":"Nat Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1124\/pr.110.002733","article-title":"Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.","volume":"62","author":"Korkmaz","year":"2010","journal-title":"Pharmacol Rev."},{"key":"B49","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.3389\/fimmu.2019.02734","article-title":"Neutrophils-important communicators in systemic lupus erythematosus and antiphospholipid syndrome.","volume":"10","author":"Wirestam","year":"2019","journal-title":"Front Immunol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1160\/TH11-09-0650","article-title":"Presence of luminal neutrophil extracellular traps in atherosclerosis.","volume":"107","author":"Megens","year":"2012","journal-title":"Thrombosis Haemostasis."},{"key":"B51","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1161\/CIRCRESAHA.117.312494","article-title":"Roles of PAD4 and NETosis in experimental atherosclerosis and arterial injury: implications for superficial erosion.","volume":"123","author":"Franck","year":"2018","journal-title":"Circ Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1055\/s-0038-1641749","article-title":"Neutrophil extracellular traps participate in all different types of thrombotic and haemorrhagic complications of coronary atherosclerosis.","volume":"118","author":"Pertiwi","year":"2018","journal-title":"Thrombosis Haemostasis."},{"key":"B53","doi-asserted-by":"publisher","first-page":"e99","DOI":"10.1161\/ATVBAHA.117.309580","article-title":"Mitochondrial oxidative stress promotes atherosclerosis and neutrophil extracellular traps in aged mice.","volume":"37","author":"Wang","year":"2017","journal-title":"Arterioscler Thrombosis Vasc Biol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1161\/ATVBAHA.113.301627","article-title":"Elevated levels of circulating DNA and chromatin are independently associated with severe coronary atherosclerosis and a prothrombotic state.","volume":"33","author":"Borissoff","year":"2013","journal-title":"Arterioscler Thrombosis Vasc Biol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1001\/jama.286.17.2136","article-title":"Association between myeloperoxidase levels and risk of coronary artery disease.","volume":"286","author":"Zhang","year":"2001","journal-title":"JAMA."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.4049\/jimmunol.180.3.1895","article-title":"Histone deimination as a response to inflammatory stimuli in neutrophils.","volume":"180","author":"Neeli","year":"2008","journal-title":"J Immunol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.3389\/fimmu.2018.01680","article-title":"Myeloid-specific deletion of peptidylarginine deiminase 4 mitigates atherosclerosis.","volume":"9","author":"Liu","year":"2018","journal-title":"Front Immunol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"928","DOI":"10.3389\/fimmu.2017.00928","article-title":"Neutrophil extracellular traps and endothelial dysfunction in atherosclerosis and thrombosis.","volume":"8","author":"Qi","year":"2017","journal-title":"Front Immunol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.4049\/jimmunol.1202388","article-title":"Neutrophil extracellular trap-associated protein activation of the NLRP3 inflammasome is enhanced in lupus macrophages.","volume":"190","author":"Kahlenberg","year":"2013","journal-title":"J Immunol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/joim.12862","article-title":"Anti-inflammatory therapy for atherosclerosis: interpreting divergent results from the CANTOS and CIRT clinical trials.","volume":"285","author":"Ridker","year":"2019","journal-title":"J Intern Med."},{"key":"B61","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1161\/CIRCULATIONAHA.119.045256","article-title":"From CANTOS to CIRT to COLCOT to clinic: will all atherosclerosis patients soon be treated with combination lipid-lowering and inflammation-inhibiting agents?","volume":"141","author":"Ridker","year":"2020","journal-title":"Circulation."},{"key":"B62","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1182\/blood-2016-11-751636","article-title":"Erythrocyte sialoglycoproteins engage Siglec-9 on neutrophils to suppress activation.","volume":"129","author":"Lizcano","year":"2017","journal-title":"Blood."},{"key":"B63","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/sj.bjp.0705291","article-title":"Effects of heparin and related molecules upon neutrophil aggregation and elastase release in vitro.","volume":"139","author":"Brown","year":"2003","journal-title":"Br J Pharmacol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/0049-3848(83)90008-7","article-title":"Neutralization of heparin by histone and its subfractions.","volume":"31","author":"Pal","year":"1983","journal-title":"Thrombosis Res."},{"key":"B65","doi-asserted-by":"publisher","first-page":"15880","DOI":"10.1073\/pnas.1005743107","article-title":"Extracellular DNA traps promote thrombosis.","volume":"107","author":"Fuchs","year":"2010","journal-title":"Proc Natl Acad Sci USA."},{"key":"B66","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cyto.2016.12.008","article-title":"Glycosaminoglycans are important mediators of neutrophilic inflammation in vivo.","volume":"91","author":"Gschwandtner","year":"2017","journal-title":"Cytokine."},{"key":"B67","doi-asserted-by":"crossref","first-page":"26S","DOI":"10.1378\/chest.124.3_suppl.26S","article-title":"The protein C pathway.","author":"Esmon","year":"2003","journal-title":"Chest."},{"key":"B68","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1182\/blood-2015-02-355974","article-title":"Activated protein C: biased for translation.","volume":"125","author":"Griffin","year":"2015","journal-title":"Blood."},{"key":"B69","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/MOH.0000000000000473","article-title":"Cell biology of activated protein C.","volume":"26","author":"Shahzad","year":"2019","journal-title":"Curr Opin Hematol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1182\/blood-2018-02-769026","article-title":"Activated protein C, protease activated receptor 1, and neuroprotection.","volume":"132","author":"Griffin","year":"2018","journal-title":"Blood."},{"key":"B71","doi-asserted-by":"publisher","first-page":"31869","DOI":"10.1016\/s0021-9258(18)31776-9","article-title":"The mechanism of inactivation of human factor V and human factor Va by activated protein C.","volume":"269","author":"Kalafatis","year":"1994","journal-title":"J Biol Chem."},{"key":"B72","doi-asserted-by":"publisher","first-page":"23105","DOI":"10.1074\/jbc.M103138200","article-title":"Secondary substrate-binding exosite in the serine protease domain of activated protein C important for cleavage at Arg-506 but not at Arg-306 in factor Va.","volume":"276","author":"Friedrich","year":"2001","journal-title":"J Biol Chem."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1046\/j.1538-7836.2003.00299.x","article-title":"Molecular recognition in the protein C anticoagulant pathway.","volume":"1","author":"Dahlback","year":"2003","journal-title":"J Thromb Haemostasis."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1111\/j.1538-7836.2006.01996.x","article-title":"Circulating activated protein C is reduced in young survivors of myocardial infarction and inversely correlates with the severity of coronary lesions.","volume":"4","author":"Zorio","year":"2006","journal-title":"J Thrombosis Haemostasis."},{"key":"B75","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S0002-9440(10)61753-1","article-title":"Down-regulation of endothelial expression of endothelial cell protein C receptor and thrombomodulin in coronary atherosclerosis.","volume":"159","author":"Laszik","year":"2001","journal-title":"Am J Pathol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.3390\/ijms20071762","article-title":"The cardioprotective signaling activity of Activated protein C in heart failure and ischemic heart diseases.","volume":"20","author":"Ren","year":"2019","journal-title":"Int J Mol Sci."},{"key":"B77","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/MCA.0b013e328010a44a","article-title":"Recombinant human-activated protein C inhibits cardiomyocyte apoptosis in a rat model of myocardial ischemia-reperfusion.","volume":"18","author":"Pirat","year":"2007","journal-title":"Coronary Artery Dis."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1161\/ATVBAHA.109.188656","article-title":"Activated protein C protects against myocardial ischemia\/reperfusion injury via inhibition of apoptosis and inflammation.","volume":"29","author":"Loubele","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1111\/j.1538-7836.2011.04331.x","article-title":"Activated protein C protects against myocardial ischemic\/reperfusion injury through AMP-activated protein kinase signaling.","volume":"9","author":"Wang","year":"2011","journal-title":"J Thrombosis Haemostasis."},{"key":"B80","doi-asserted-by":"publisher","first-page":"9251","DOI":"10.1074\/jbc.M610547200","article-title":"Engineering a disulfide bond to stabilize the calcium-binding loop of activated protein C eliminates its anticoagulant but not its protective signaling properties.","volume":"282","author":"Bae","year":"2007","journal-title":"J Biol Chem."},{"key":"B81","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1182\/blood-2017-05-782102","article-title":"Cytoprotective activated protein C averts Nlrp3 inflammasome-induced ischemia-reperfusion injury via mTORC1 inhibition.","volume":"130","author":"Nazir","year":"2017","journal-title":"Blood."},{"key":"B82","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1161\/01.RES.0000261924.76669.36","article-title":"Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy.","volume":"100","author":"Matsui","year":"2007","journal-title":"Circ Res."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1111\/j.1538-7836.2012.04833.x","article-title":"Activated protein C modulates cardiac metabolism and augments autophagy in the ischemic heart.","volume":"10","author":"Costa","year":"2012","journal-title":"J Thrombosis Haemostasis."},{"key":"B84","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1161\/circresaha.120.317219","article-title":"Different DOACs control inflammation in cardiac ischemia-reperfusion differently.","volume":"128","author":"Gadi","year":"2021","journal-title":"Circ Res."},{"key":"B85","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1016\/j.bbrc.2017.12.125","article-title":"Activated protein C protects against pressure overload-induced hypertrophy through AMPK signaling.","volume":"495","author":"Cates","year":"2018","journal-title":"Biochem Biophys Res Commun."},{"key":"B86","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s42003-018-0108-5","article-title":"Activated protein C reverses epigenetically sustained p66(Shc) expression in plaque-associated macrophages in diabetes.","volume":"1","author":"Shahzad","year":"2018","journal-title":"Commun Biol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"e45663","DOI":"10.1371\/journal.pone.0045663","article-title":"Treatment with activated protein C (aPC) is protective during the development of myocardial fibrosis: an angiotensin II infusion model in mice.","volume":"7","author":"Sopel","year":"2012","journal-title":"PLoS One."},{"key":"B88","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1172\/JCI119454","article-title":"Anticoagulant synergism of heparin and activated protein C in vitro. Role of a novel anticoagulant mechanism of heparin, enhancement of inactivation of factor V by activated protein C.","volume":"99","author":"Petaja","year":"1997","journal-title":"J Clin Invest."},{"key":"B89","doi-asserted-by":"publisher","first-page":"17965","DOI":"10.1016\/s0021-9258(17)32404-3","article-title":"Glycosaminoglycan contributions to both protein C activation and thrombin inhibition involve a common arginine-rich site in thrombin that includes residues arginine 93, 97, and 101.","volume":"269","author":"Ye","year":"1994","journal-title":"J Biol Chem."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1046\/j.1538-7836.2003.00305.x","article-title":"Mechanisms of glycosaminoglycan activation of the serpins in hemostasis.","volume":"1","author":"Huntington","year":"2003","journal-title":"J Thrombosis Haemostasis."},{"key":"B91","doi-asserted-by":"publisher","first-page":"4195","DOI":"10.1021\/bi0617299","article-title":"In the presence of phospholipids, glycosaminoglycans potentiate factor Xa-mediated protein C activation by modulating factor Xa activity.","volume":"46","author":"McRae","year":"2007","journal-title":"Biochemistry."},{"key":"B92","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.thromres.2018.07.026","article-title":"Dual antiplatelet and anticoagulant (APAC) heparin proteoglycan mimetic with shear-dependent effects on platelet-collagen binding and thrombin generation.","volume":"169","author":"Chen","year":"2018","journal-title":"Thrombosis Res."},{"key":"B93","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/FJC.0000000000001080","article-title":"Safety and functional pharmacokinetic profile of APAC, a novel intravascular antiplatelet and anticoagulant.","volume":"78","author":"Craige","year":"2021","journal-title":"J Cardiovasc Pharmacol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1007\/s10157-016-1308-2","article-title":"Dual antiplatelet and anticoagulant APAC prevents experimental ischemia-reperfusion-induced acute kidney injury.","volume":"21","author":"Tuuminen","year":"2017","journal-title":"Clin Exp Nephrol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s00216-021-03765-y","article-title":"AFM investigation of APAC (antiplatelet and anticoagulant heparin proteoglycan).","volume":"414","author":"Winzely","year":"2022","journal-title":"Anal Bioanal Chem."},{"key":"B96","doi-asserted-by":"publisher","first-page":"e46840","DOI":"10.7554\/eLife.46840","article-title":"Heparan sulfates are critical regulators of the inhibitory megakaryocyte-platelet receptor G6b-B.","volume":"8","author":"Vogtle","year":"2019","journal-title":"eLife."},{"key":"B97","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1182\/blood-2005-05-1994","article-title":"A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2.","volume":"107","author":"Suzuki-Inoue","year":"2006","journal-title":"Blood."},{"key":"B98","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1074\/jbc.M610383200","article-title":"The crystal structure and mutational binding analysis of the extracellular domain of the platelet-activating receptor CLEC-2.","volume":"282","author":"Watson","year":"2007","journal-title":"J Biol Chem."},{"key":"B99","doi-asserted-by":"publisher","first-page":"688643","DOI":"10.3389\/fimmu.2021.688643","article-title":"The role of CLEC-2 and its ligands in thromboinflammation.","volume":"12","author":"Meng","year":"2021","journal-title":"Front Immunol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1055\/s-0037-1604090","article-title":"Platelet CLEC-2: roles beyond hemostasis.","volume":"44","author":"Suzuki-Inoue","year":"2018","journal-title":"Semin Thrombosis Hemostasis."},{"key":"B101","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1080\/09537104.2021.1906407","article-title":"The structure of CLEC-2: mechanisms of dimerization and higher-order clustering.","volume":"32","author":"Martin","year":"2021","journal-title":"Platelets."},{"key":"B102","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1038\/s41467-017-02402-6","article-title":"The podoplanin-CLEC-2 axis inhibits inflammation in sepsis.","volume":"8","author":"Rayes","year":"2017","journal-title":"Nat Commun."},{"key":"B103","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.ejvs.2019.05.019","article-title":"Novel locally acting dual antiplatelet and anticoagulant (APAC) targets multiple sites of vascular injury in an experimental porcine model.","volume":"58","author":"Barreiro","year":"2019","journal-title":"Eur J Vasc Endovasc Surg."},{"key":"B104","doi-asserted-by":"publisher","first-page":"e341","DOI":"10.1097\/TXD.0000000000000881","article-title":"Complement-mediated damage to the glycocalyx plays a role in renal ischemia-reperfusion injury in mice.","volume":"5","author":"Bongoni","year":"2019","journal-title":"Transplant Direct."},{"key":"B105","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1161\/ATVBAHA.107.151456","article-title":"PECAM-1: a multi-functional molecule in inflammation and vascular biology.","volume":"27","author":"Woodfin","year":"2007","journal-title":"Arterioscler Thrombosis Vasc Biol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"9419","DOI":"10.1038\/s41598-020-64907-3","article-title":"Distinct functional requirements for podocalyxin in immature and mature podocytes reveal mechanisms of human kidney disease.","volume":"10","author":"Refaeli","year":"2020","journal-title":"Sci Rep."},{"key":"B107","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1083\/jcb.102.2.484","article-title":"Endothelial cell membranes contain podocalyxin\u2013the major sialoprotein of visceral glomerular epithelial cells.","volume":"102","author":"Horvat","year":"1986","journal-title":"J Cell Biol."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.866751\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T07:56:53Z","timestamp":1648713413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.866751\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,31]]},"references-count":107,"alternative-id":["10.3389\/fcvm.2022.866751"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.866751","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,31]]},"article-number":"866751"}}